Rhinosinusitis Drug Market Trends Are Creating New Opportunities For Industry Leaders
Rhinosinusitis Drug market size reached $0.84 billion in 2026 and is expected to grow to $1.19 billion by 2030 at a 9.2% CAGR. Major players: Roche Holding AG, Pfizer Inc., AbbVie Inc.

